Elínborg Ostermann

Effective Immunoconjugate Therapy in Cancer Models Targeting a Serine Protease of Tumor Fibroblasts

Elínborg Ostermann, Pilar Garin‐Chesa, Karl Heinz Heider et al. · Clinical Cancer Research · 2008 · 241 citations · Full text

Medicine, Immunology, Oncology +17

A novel Fc-engineered monoclonal antibody to CD37 with enhanced ADCC and high proapoptotic activity for treatment of B-cell malignancies

Karl‐Heinz Heider, Kerstin Kiefer, Thorsten Zenz et al. · Blood · 2011 · 103 citations · Full text

Pharmacy, Immunology, Oncology +15

Pharmacodynamic and Antineoplastic Activity of BI 836845, a Fully Human IGF Ligand-Neutralizing Antibody, and Mechanistic Rationale for Combination with Rapamycin

Katrin Friedbichler, Marco H. Hofmann, Monika Kroez et al. · Molecular Cancer Therapeutics · 2013 · 99 citations · Full text

Medicine, Oncology, Pharmacology +16

Allelic Frequencies and Patterns of Single-nucleotide Polymorphisms in Candidate Genes for Asthma and Atopy in Iceland

Håkon Håkonarson, Unnur Steina Björnsdóttir, Elínborg Ostermann et al. · American Journal of Respiratory and Critical Care Medicine · 2001 · 92 citations

Life Sciences, Genetics, Molecular Genetics +17

Tumor-targeted gene delivery of tumor necrosis factor-α induces tumor necrosis and tumor regression without systemic toxicity

Ralf Kircheis, Elínborg Ostermann, Markus Wolschek et al. · Cancer Gene Therapy · 2002 · 86 citations

Pharmacy, Oncology, Pharmaceutics +16